The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period

Cancer Research

Volumn 66, Issue 21, 2006, Pages 10630-10636

  Kjaer, Susanne ^a,b   Høgdall, Estrid ^a   Frederiksen, Kirsten ^a   Munk, Christian ^a   Van Den Brule, Adriaan ^c   Svare, Edith ^a   Meijer, Chris ^d   Lorincz, Attilla ^e   Iftner, Thomas ^f  

^a INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^b Rigshospitalet   (Denmark)

^c Stichting Laboratoria voor Pathologie en Medische Microbiologie   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e Digene Corporation   (United States)

^f UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; CYTOLOGY; DENMARK; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DISEASE; WART VIRUS;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PROSPECTIVE STUDIES; RISK; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 33751164570     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-1057     Document Type: Article

References (15)

1. Walboomers JM, Jacobs MV, Manos MM, et al. Human papiliomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9.
2. Kjaer SK, van den Brule AJC, Paull G, et al. Type-specific persistence of high-risk human papiliomavirus (HPV) is the major indicator of high-grade cervical squamous intraepithelial lesions (SIL) in 20-29 years old women. BMJ 2002;325:572-3.
3. Schlect NF, Kulafa S, Robitaille J, et al. Persistent human papiliomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 2001;286:3106-14.
4. Woodman CB, Collins S, Winther H, et al. Natural history of cervical human papiliomavirus in young women: a longitudinal cohort study. Lancet 2001;357:1831-6.
5. Vizcaino AP, Moreno V, Bosch FX et al. International trends in incidence of cervical cancer: II. Squamous cell carcinoma. Int J Cancer 2000;86:429-35.
6. Kyndi M, Frederiksen K, Kjaer SK. Cervical cancer incidence in Denmark over six decades (1943-2002). Acta Obstet Gynecol Scand 2006;85:106-11.
7. Nanda K, McCrory DC, Myers ER, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med 2000;132:810-9.
8. Castle PE, Wacholder S, Sherman M, et al. Absolute risk of a subsequent abnormal Pap among oncogenic human papillomavirus DNA-positive cytologically negative women. Cancer 2002;95:2145-51.
9. Moscicki AB, Hills N, Shiboski S, et al. Risk for incident human papillomavirus infection and low-grade intraepithelial lesion development in young females. JAMA 2001;285:2995-3002.
10. Kjaer SK, van den Brule AJC, Bock JE, et al. Human papillomavirus-the most significant risk determinant of cervical intraepithelial neoplasia. A population-based prospective cohort study from Copenhagen. Int J Cancer 1996;65:601-6.
11. Iftner T, Villa L. Human papillomavirus technologies. J Natl Cancer Inst Monogr 2003;31:80-8.
12. Carstensen B. Regression models for interval censored survival data: application to HIV infection on Danish homosexual men. Stat Med 1996;15:2177-89.
13. Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patinets with atypical squamous cells of undetermined significance: baseline results from a randomised trial. J Natl Cancer Inst 2001;93:293-9.
14. Khan MJ, Castle PE, Lorincz AT, et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 2005;97:1072-91.
15. Schiffman M, Herrero R, desalle R, et al. The carcinogenicity of human papillomavirus types reflects viral evolution. Virology 2005;337:76-84.